Prof. Dr. med. Ulrich Wahn

Arzt für pädiatrische Pneumologie und AllergologiePhysician for pediatric pneumology and allergology

Stacks Image 635
Stacks Image 638

Journalbeiträge 2004


  • Ahrens B., Lammert I., Schmitt M., Wahn U., Paul K. & Niggemann B.: Life-threatening vallecular cyst in a 3-month-old infant: case report and literature review. Clin Pediatr: 43(3) 287-90, 2004
  • Asher-I,-Baena-Cagnani-C,-Boner-A,-Canonica-GW,-Chuchalin-A,-Custovic-A,-Dagli-E,-Haahtela-T,-Haus-M,-Lemmo-Hoten-M,-Holgate-S,-Holloway-J,-Holt-P,-Host-A,-Iikura-Y,-Johansson-SG,-Kaplan-A,-Kowalski-ML,-Lockey-RF,-Naspitz-C,-Odhiambo-J,-Ring-J,-Sastre-J,-Venables-K,-Vichyanond-P,-Volovitz-B,-Wahn-U,-Warner-J,-Weiss-K,-Zhong N.S. & World Allergy Organization: World Allergy Organization guidelines for prevention of allergy and allergic asthma. Int Arch Allergy Imm: 135(1) 83-92, 2004
  • Blümchen K., Gerhold K., Thorade I., Seib C., Wahn U. & Hamelmann E.: Oral administration of desloratadine prior to sensitization prevents allergen-induced airway inflammation and hyper-reactivity in mice. Clin Exp Allergy: 34(7) 1124-30, 2004
  • Chen C.I., Schaller-Bals S., Paul K.P., Wahn U. & Bals R.: Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J Cyst Fibros: 3(1) 45-50, 2004
  • Holt P.G., Sly P.D., Martinez F.D., Weiss S.T., Björkstén B., von Mutius E. & Wahn U.: Drug development strategies for asthma: in search of a new paradigm. Nat Immunol: 5(7) 695-8, 2004
  • Illi S, von Mutius E, Lau S, Nickel R, Gruber C, Niggemann B, Wahn U. & Multicenter Allergy Study Group: The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immun: 113(5) 925-31, 2004
  • Liu X., Beaty T.H., Deindl P., Huang S.K., Lau S., Sommerfeld C., Fallin M.D., Kao W.H., Wahn U. & Nickel R.: Associations between specific serum IgE response and 6 variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study. J Allergy Clin Immun: 113(3) 489-95, 2004
  • Meltzer E.O., Scheinmann P., Rosado Pinto J.E., Bachert C., Hedlin G., Wahn U., Finn A.F. & Ruuth E.: Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies. Pediatr Allergy Immu: 15(3) 253-60, 2004
  • Muraro A., Dreborg S., Halken S., Høst A., Niggemann B., Aalberse R., Arshad S.H., Berg Av A., Carlsen K., Duschén K., Eigenmann P., Hill D., Jones C., Mellon M., Oldeus G., Oranje A., Pascual C., Prescott S., Sampson H., Svartengren M., Vandenplas Y., Wahn U., Warner J.A., Warner J.O., Wickman M. & Zeiger R.S.: Dietary prevention of allergic diseases in infants and small children. Part I: immunologic background and criteria for hypoallergenicity. Pediatr Allergy Immu: 15(2) 103-11, 2004
  • Muraro A., Dreborg S., Halken S., Høst A., Niggemann B., Aalberse R., Arshad S.H., Berg Av A., Carlsen K.H., Duschén K., Eigenmann P., Hill D., Jones C., Mellon M., Oldeus G., Oranje A., Pascual C., Prescott S., Sampson H., Svartengren M., Vandenplas Y., Wahn U., Warner J.A., Warner J.O., Wickman M. & Zeiger R.S.: Dietary prevention of allergic diseases in infants and small children. Part III: Critical review of published peer-reviewed observational and interventional studies and final recommendations. Pediatr Allergy Immu: 15(4) 291-307, 2004
  • Muraro A., Dreborg S., Halken S., Høst A., Niggemann B., Aalberse R., Arshad S.H., von Berg A., Carlsen K.H., Duschén K., Eigenmann P., Hill D., Jones C., Mellon M., Oldeus G., Oranje A., Pascual C., Prescott S., Sampson H., Svartengren M., Vandenplas Y., Wahn U., Warner J.A., Warner J.O., Wickman M. & Zeiger R.S.: Dietary prevention of allergic diseases in infants and small children. Part II: Evaluation of methods in allergy prevention studies and sensitization markers. Definitions and diagnostic criteria of allergic diseases. Pediatr Allergy Immu: 15(3) 196-205, 2004
  • Niggemann B., Celik-Bilgili S., Ziegert M., Reibel S., Sommerfeld C. & Wahn U.: Specific IgE levels do not indicate persistence or transience of food allergy in children with atopic dermatitis. J Invest Allerg Clin: 14(2) 98-103, 2004
  • Paul K., Rietschel E., Ballmann M., Griese M., Worlitzsch D., Shute J., Chen C., Schink T., Doring G., van Koningsbruggen S., Wahn U. & Ratjen F.: Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis. Am J Resp Crit Care: 169(6) 719-25. Epub 2003 Dec 18., 2004
  • Rolinck-Werninghaus-C,-Hamelmann-E,-Keil-T,-Kulig-M,-Koetz-K,-Gerstner-B,-Kuehr-J,-Zielen-S,-Schauer-U,-Kamin-W,-Von-Berg-A,-Hammermann-J,-Weinkauf-B,-Weidinger-G,-Stenglein-S,-Wahn U. & Omalizumab Rhinitis Study Group: The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children. Allergy: 59(9) 973-9, 2004
  • Rolinck-Werninghaus C., Wolf H., Liebke C., Baars J.C., Lange J., Kopp M.V., Hammermann J., Leupold W., Bartels P., Gruebl A., Bauer C.P., Schnitker J., Wahn U. & Niggemann B.: A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy: 59(12) 1285-93, 2004
  • Sengler C., Gaedicke G., Wahn U. & Keitzer R.: Pulmonary symptoms in Kawasaki disease. Pediatr Infect Dis J: 23(8) 782-4, 2004
  • Stock P., Kallinich T., Akbari O., Quarcoo D., Gerhold K., Wahn U., Umetsu D.T. & Hamelmann E.: CD8(+) T cells regulate immune responses in a murine model of allergen-induced sensitization and airway inflammation. Eur J Immunol: 34(7) 1817-27, 2004
  • Wahn U., Chuchalin A. & Kowalski M.L.: Prediction and early diagnosis. Chem Immunol Allergy: 84 128-34, 2004
  • Wahn U. & Hamelmann E.: Anti-IgE therapy. Clin Allergy Immunol: 18 625-40, 2004

Journal Articles 2004


  • Ahrens B., Lammert I., Schmitt M., Wahn U., Paul K. & Niggemann B.: Life-threatening vallecular cyst in a 3-month-old infant: case report and literature review. Clin Pediatr: 43(3) 287-90, 2004
  • Asher-I,-Baena-Cagnani-C,-Boner-A,-Canonica-GW,-Chuchalin-A,-Custovic-A,-Dagli-E,-Haahtela-T,-Haus-M,-Lemmo-Hoten-M,-Holgate-S,-Holloway-J,-Holt-P,-Host-A,-Iikura-Y,-Johansson-SG,-Kaplan-A,-Kowalski-ML,-Lockey-RF,-Naspitz-C,-Odhiambo-J,-Ring-J,-Sastre-J,-Venables-K,-Vichyanond-P,-Volovitz-B,-Wahn-U,-Warner-J,-Weiss-K,-Zhong N.S. & World Allergy Organization: World Allergy Organization guidelines for prevention of allergy and allergic asthma. Int Arch Allergy Imm: 135(1) 83-92, 2004
  • Blümchen K., Gerhold K., Thorade I., Seib C., Wahn U. & Hamelmann E.: Oral administration of desloratadine prior to sensitization prevents allergen-induced airway inflammation and hyper-reactivity in mice. Clin Exp Allergy: 34(7) 1124-30, 2004
  • Chen C.I., Schaller-Bals S., Paul K.P., Wahn U. & Bals R.: Beta-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J Cyst Fibros: 3(1) 45-50, 2004
  • Holt P.G., Sly P.D., Martinez F.D., Weiss S.T., Björkstén B., von Mutius E. & Wahn U.: Drug development strategies for asthma: in search of a new paradigm. Nat Immunol: 5(7) 695-8, 2004
  • Illi S, von Mutius E, Lau S, Nickel R, Gruber C, Niggemann B, Wahn U. & Multicenter Allergy Study Group: The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immun: 113(5) 925-31, 2004
  • Liu X., Beaty T.H., Deindl P., Huang S.K., Lau S., Sommerfeld C., Fallin M.D., Kao W.H., Wahn U. & Nickel R.: Associations between specific serum IgE response and 6 variants within the genes IL4, IL13, and IL4RA in German children: the German Multicenter Atopy Study. J Allergy Clin Immun: 113(3) 489-95, 2004
  • Meltzer E.O., Scheinmann P., Rosado Pinto J.E., Bachert C., Hedlin G., Wahn U., Finn A.F. & Ruuth E.: Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies. Pediatr Allergy Immu: 15(3) 253-60, 2004
  • Muraro A., Dreborg S., Halken S., Høst A., Niggemann B., Aalberse R., Arshad S.H., Berg Av A., Carlsen K., Duschén K., Eigenmann P., Hill D., Jones C., Mellon M., Oldeus G., Oranje A., Pascual C., Prescott S., Sampson H., Svartengren M., Vandenplas Y., Wahn U., Warner J.A., Warner J.O., Wickman M. & Zeiger R.S.: Dietary prevention of allergic diseases in infants and small children. Part I: immunologic background and criteria for hypoallergenicity. Pediatr Allergy Immu: 15(2) 103-11, 2004
  • Muraro A., Dreborg S., Halken S., Høst A., Niggemann B., Aalberse R., Arshad S.H., Berg Av A., Carlsen K.H., Duschén K., Eigenmann P., Hill D., Jones C., Mellon M., Oldeus G., Oranje A., Pascual C., Prescott S., Sampson H., Svartengren M., Vandenplas Y., Wahn U., Warner J.A., Warner J.O., Wickman M. & Zeiger R.S.: Dietary prevention of allergic diseases in infants and small children. Part III: Critical review of published peer-reviewed observational and interventional studies and final recommendations. Pediatr Allergy Immu: 15(4) 291-307, 2004
  • Muraro A., Dreborg S., Halken S., Høst A., Niggemann B., Aalberse R., Arshad S.H., von Berg A., Carlsen K.H., Duschén K., Eigenmann P., Hill D., Jones C., Mellon M., Oldeus G., Oranje A., Pascual C., Prescott S., Sampson H., Svartengren M., Vandenplas Y., Wahn U., Warner J.A., Warner J.O., Wickman M. & Zeiger R.S.: Dietary prevention of allergic diseases in infants and small children. Part II: Evaluation of methods in allergy prevention studies and sensitization markers. Definitions and diagnostic criteria of allergic diseases. Pediatr Allergy Immu: 15(3) 196-205, 2004
  • Niggemann B., Celik-Bilgili S., Ziegert M., Reibel S., Sommerfeld C. & Wahn U.: Specific IgE levels do not indicate persistence or transience of food allergy in children with atopic dermatitis. J Invest Allerg Clin: 14(2) 98-103, 2004
  • Paul K., Rietschel E., Ballmann M., Griese M., Worlitzsch D., Shute J., Chen C., Schink T., Doring G., van Koningsbruggen S., Wahn U. & Ratjen F.: Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis. Am J Resp Crit Care: 169(6) 719-25. Epub 2003 Dec 18., 2004
  • Rolinck-Werninghaus-C,-Hamelmann-E,-Keil-T,-Kulig-M,-Koetz-K,-Gerstner-B,-Kuehr-J,-Zielen-S,-Schauer-U,-Kamin-W,-Von-Berg-A,-Hammermann-J,-Weinkauf-B,-Weidinger-G,-Stenglein-S,-Wahn U. & Omalizumab Rhinitis Study Group: The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children. Allergy: 59(9) 973-9, 2004
  • Rolinck-Werninghaus C., Wolf H., Liebke C., Baars J.C., Lange J., Kopp M.V., Hammermann J., Leupold W., Bartels P., Gruebl A., Bauer C.P., Schnitker J., Wahn U. & Niggemann B.: A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy: 59(12) 1285-93, 2004
  • Sengler C., Gaedicke G., Wahn U. & Keitzer R.: Pulmonary symptoms in Kawasaki disease. Pediatr Infect Dis J: 23(8) 782-4, 2004
  • Stock P., Kallinich T., Akbari O., Quarcoo D., Gerhold K., Wahn U., Umetsu D.T. & Hamelmann E.: CD8(+) T cells regulate immune responses in a murine model of allergen-induced sensitization and airway inflammation. Eur J Immunol: 34(7) 1817-27, 2004
  • Wahn U., Chuchalin A. & Kowalski M.L.: Prediction and early diagnosis. Chem Immunol Allergy: 84 128-34, 2004
  • Wahn U. & Hamelmann E.: Anti-IgE therapy. Clin Allergy Immunol: 18 625-40, 2004